PRESS RELEASE A syndicated loan amounting to GRD 22 billion has been signed in London by Sarantis and a group of Greek and foreign banks.The organization of the loan, whose terms and conditions are rather beneficial for Sarantis, was undertaken by EFG FINANCE SA and ALPHA BANK SA, while 9 banking institutions participated in the final group.
PRESS RELEASE Johnson & Johnson and Sarantis have signed an agreement concerning the exclusive distribution of Johnson & Johnson products in Romania by ROMSAR, a fully owned subsidiary of GR. SARANTIS S.
PRESS RELEASE A joint venture cooperation preliminary agreement between Estee Lauder Companies and Sarantis Group of Companies was signed concerning Greece and the Balkans. In the agreement the start up of a new company is mentioned, which will manage the interests of the Companies of Estee Lauder in the area of the Balkans with headquarters in Athens.
PRESS RELEASE In the first quarter of 2000, SARANTIS Group consolidated balance sheet presents 28% increase in sales and +12% in profits. More specifically, the consolidated sales reached 10,8 billion Drs.
PRESS RELEASE Τhe final agreement for the formation of a Joint Venture company between Estee Lauder Europe Inc and Zeta Cosmetics Ltd, an affiliate of Gr. Sarantis S.A. group was signed in New York. The name of the new company is ELCA Cosmetics Limited.
PRESS RELEASE The consolidated sales of the Sarantis Group for the first quarter of 2001 have increased by 26%, as compared to the relevant period of the year 2000. More specifically, Sarantis’ turnover for the period January-March 2001, amounted to GRD 13,7 billion, as compared to GRD 10,8 billion for the same period of the year 2000.
PRESS RELEASE The consolidated results of the Sarantis Group displayed a growth in sales of 19% and earnings of 10% in the first half of 2000, compared to the first half of 1999. In terms of operating profits, Sarantis shows an impressive growth of 70% in comparison to the corresponding period last year.
PRESS RELEASE A preliminary contract for the sale of 49% of the K.P. MARINOPOULOS S.A. shares to GR. SARANTIS S.A. was signed. K.P. MARINOPOULOS S.A. is concerned with the distribution and representation of pharmaceutical products with a significant export activity.